Honesty Pharmaceuticals and the Gods of Innovation have reached an exclusive partnership agreement for innovative cancer drugs in Greater China.

On November 12, 2025, Hangzhou Baicheng Pharmaceutical Technology Co., Ltd. and Zhejiang Zhongshen Innovative Pharmaceutical Technology Co., Ltd. reached an exclusive authorization cooperation agreement for the innovative drug BIOS-0629 project in the Greater China region, and signed a cooperation agreement. After the cooperation product is launched in the Greater China region, Baicheng Pharmaceutical is entitled to a 10% share of the sales revenue.